(Total Views: 375)
Posted On: 02/27/2020 10:05:23 AM
Post# of 149238
Quote:
I honestly wish we would quit going there and stay away from a Chinese partnership on that indication. If we have a Chinese co that wants to license for cancer and we can protect our patent, maybe, but I will pass on some short term hype that the rest of the pharma world is chasing.
It didn't have to be Chinese partnership. Example, we ran a small animal study with previous coronavirus strains and mice with leronlimab had 100% survival while percentage of mice without died. SP would be $2 today. Maybe hype, maybe pandemic next year, we don't know yet.
(1)
(0)Scroll down for more posts ▼
